WT1-CTLs generated from 3 different donors were able to kill primary AML samples at E:T ratios ranging from 1 to 10, with killing plateauing at an E:T of 5–10 (Fig. 6B shows 2 representative patients). The gene discussed is WT1; the disease is acute myeloid leukemia.